The role of uridine adenosine tetraphosphate in the vascular system
- PMID: 22110488
- PMCID: PMC3206368
- DOI: 10.1155/2011/435132
The role of uridine adenosine tetraphosphate in the vascular system
Abstract
The endothelium plays a pivotal role in vascular homeostasis, and endothelial dysfunction is a major feature of cardiovascular diseases, such as arterial hypertension, atherosclerosis, and diabetes. Recently, uridine adenosine tetraphosphate (Up(4)A) has been identified as a novel and potent endothelium-derived contracting factor (EDCF). Up(4)A structurally contains both purine and pyrimidine moieties, which activate purinergic receptors. There is an accumulating body of evidence to show that Up(4)A modulates vascular function by actions on endothelial and smooth muscle cells. In this paper, we discuss the effects of Up(4)A on vascular function and a potential role for Up(4)A in cardiovascular diseases.
Figures

Similar articles
-
Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.Br J Pharmacol. 2015 Aug;172(16):3980-4001. doi: 10.1111/bph.13205. Epub 2015 Jul 8. Br J Pharmacol. 2015. PMID: 26031319 Free PMC article. Review.
-
Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.Pharmacol Res. 2019 Mar;141:32-45. doi: 10.1016/j.phrs.2018.12.009. Epub 2018 Dec 13. Pharmacol Res. 2019. PMID: 30553823 Free PMC article. Review.
-
The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation.J Mol Med (Berl). 2011 Aug;89(8):799-810. doi: 10.1007/s00109-011-0750-6. Epub 2011 Apr 13. J Mol Med (Berl). 2011. PMID: 21487675
-
Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor.Nat Med. 2005 Feb;11(2):223-7. doi: 10.1038/nm1188. Epub 2005 Jan 23. Nat Med. 2005. PMID: 15665829
-
Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H409-17. doi: 10.1152/ajpheart.00084.2011. Epub 2011 May 6. Am J Physiol Heart Circ Physiol. 2011. PMID: 21551273 Free PMC article.
Cited by
-
The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates.J Mol Med (Berl). 2013 Sep;91(9):1095-107. doi: 10.1007/s00109-013-1036-y. Epub 2013 May 1. J Mol Med (Berl). 2013. PMID: 23636508
-
Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.Br J Pharmacol. 2015 Aug;172(16):3980-4001. doi: 10.1111/bph.13205. Epub 2015 Jul 8. Br J Pharmacol. 2015. PMID: 26031319 Free PMC article. Review.
-
Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids.Front Pharmacol. 2018 Mar 26;9:255. doi: 10.3389/fphar.2018.00255. eCollection 2018. Front Pharmacol. 2018. PMID: 29632487 Free PMC article.
-
Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice.Purinergic Signal. 2017 Dec;13(4):591-600. doi: 10.1007/s11302-017-9586-z. Epub 2017 Sep 20. Purinergic Signal. 2017. PMID: 28929376 Free PMC article.
-
The "artificial artery" as in vitro perfusion model.PLoS One. 2013;8(3):e57227. doi: 10.1371/journal.pone.0057227. Epub 2013 Mar 7. PLoS One. 2013. PMID: 23505419 Free PMC article.
References
-
- Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109(21, supplement 1):II27–II33. - PubMed
-
- Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) American Journal of Physiology. 2006;291(3):H985–H1002. - PubMed
-
- Cannon RO., III Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clinical Chemistry. 1998;44(8):1809–1819. - PubMed
-
- Tang EH, Vanhoutte PM. Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Archiv European Journal of Physiology. 2010;459(6):995–1004. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources